Muscarinic agonists
US11091456B2 · kind B2 · utility
9Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2019 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Aug 21, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4523
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1a) or a salt thereof, wherein p, q, r, s, Q, R3 and R4 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.